efficacy and safety of Sintilimab plus Bevacizumab for high-risk multiple ground-glass nodules in synchronous stage I non-small cell lung cancer patients: a phase II clinical trial

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2021
This article has no abstract
Epistemonikos ID: b82eac61cc1d72ece0ec22168c4f7d449abd6fb7
First added on: Apr 08, 2025